From Polyclonal to Monoclonal Antibodies: Cloud-Clone Builds a Global Benchmark for Diverse Research Antibodies via Full In-House R&D
KATY, TX / ACCESS Newswire / July 20, 2026 / As life science research grows more refined and diversified, antibodies are no longer mere lab tools-they have become critical determinants of research data reliability. With continuously segmented target studies and evolving experimental workflows, mult…